BioMarin accuses rivals of stockpiling infringing medication in complaint to USITC
BioMarin Pharmaceutical filed a complaint at the US International Trade Commission accusing Ascendis Pharma and Wacker Biotech of importing illegal quantities of C-type natriuretic peptides into the US in preparation for...To view the full article, register now.
Already a subscriber? Click here to view full article